Eton Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Eton Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -36.3 %, a 335% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Return On Equity for 2023 was -6.21 %, a 91.3% increase from 2022.
  • Eton Pharmaceuticals, Inc. annual Return On Equity for 2022 was -70.9 %, a 585% decline from 2021.
  • Eton Pharmaceuticals, Inc. annual Return On Equity for 2021 was -10.4 %, a 96.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -6.21 +64.7 +91.3% Jan 1, 2023 Dec 31, 2023
2022 -70.9 -60.6 -585% Jan 1, 2022 Dec 31, 2022
2021 -10.4 +312 +96.8% Jan 1, 2021 Dec 31, 2021
2020 -322 -198 -159% Jan 1, 2020 Dec 31, 2020
2019 -125 -529 -131% Jan 1, 2019 Dec 31, 2019
2018 405 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.